Ocrelizumab first investigational medicine to show efficacy in people with primary progressive multiple sclerosis in large Phase III study

Very important result for progressive MS management.

For the first time, a drug revealed to be effective in preventing disability worsening in primary progressive MS in a large phase III trial.

Complete results are expected at the ECTRIMS congress in Barcelona next week.

via Roche 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s